Rodrigo Alonso

Summary

Country: Spain

Publications

  1. doi request reprint Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation
    Rodrigo Alonso
    Department of Internal Medicine, IIS Fundación Jiménez Díaz, Madrid, Spain Electronic address
    J Am Coll Cardiol 63:1982-9. 2014
  2. doi request reprint Early diagnosis and treatment of familial hypercholesterolemia: improving patient outcomes
    Rodrigo Alonso
    Lipid Clinic, Internal Medicine Department, IIS Fundación Jiménez Díaz, Madrid, Spain
    Expert Rev Cardiovasc Ther 11:327-42. 2013
  3. doi request reprint Cardiovascular disease in familial hypercholesterolaemia: influence of low-density lipoprotein receptor mutation type and classic risk factors
    R Alonso
    Lipid Clinic, Fundacion Jimenez Diaz, Madrid, Spain
    Atherosclerosis 200:315-21. 2008
  4. pmc R353Q polymorphism in the factor VII gene and cardiovascular risk in Heterozygous Familial Hypercholesterolemia: a case-control study
    Juan Criado-García
    Lipids and Atherosclerosis Unit, Department of Medicine, IMIBIC Hospital Universitario Reina Sofía Universidad de Córdoba, Spain
    Lipids Health Dis 10:50. 2011
  5. pmc Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART)
    Nelva Mata
    Department of Epidemiology, Madrid Health Authority and Fundación Hipercolesterolemia Familiar, Madrid, Spain
    Lipids Health Dis 10:94. 2011
  6. doi request reprint Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study)
    Leopoldo Perez de Isla
    From the Cardiology Department, Hospital Clinico San Carlos, IdISSC, Madrid, Spain L P d I Fundación Hipercolesterolemia Familiar, Madrid, Spain L P d I, R A, N M, A s, P M Clínica las Condes, Santiago de Chile, Chile R A Department of Epidemiology, Madrid Health Authority, Spain N M Cardiology Department, Hospital del Tajo, Aranjuez, Madrid, Spain A S Department of Internal Medicine, Hospital Virgen del Rocio, Sevilla, Spain O M Department of Internal Medicine, Hospital SAS de Jerez de la Frontera, Cadiz, Spain P R M Department of Internal Medicine, Hospital Abente y Lago, A Coruna, Spain J L D D Department of Internal Medicine, Hospital Universitario, Reina Sofia, Cordoba, Spain F F Department of Internal Medicine, Fundacion Jimenez Diaz, Madrid, Spain R d A Lipid Clinic, Endocrinology Service Hospital Clínic, Barcelona
    Arterioscler Thromb Vasc Biol 36:2004-10. 2016
  7. ncbi request reprint Benefits and risks assessment of simvastatin in familial hypercholesterolaemia
    Rodrigo Alonso
    Fundacion Jimenez Diaz, Lipid Clinic, Internal Medicine Department, Madrid 28040, Spain
    Expert Opin Drug Saf 4:171-81. 2005
  8. doi request reprint Attainment of LDL Cholesterol Treatment Goals in Children and Adolescents With Familial Hypercholesterolemia. The SAFEHEART Follow-up Registry
    Adriana Saltijeral
    Sección de Cardiología, Hospital Universitario del Tajo, Universidad Alfonso X El Sabio, Aranjuez, Madrid, Spain Electronic address
    Rev Esp Cardiol (Engl Ed) . 2016
  9. doi request reprint Detection of subclinical atherosclerosis in familial hypercholesterolemia using non-invasive imaging modalities
    Paloma Caballero
    Department of Radiology, Hospital de la Princesa, Madrid, Spain
    Atherosclerosis 222:468-72. 2012
  10. doi request reprint Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up
    Leopoldo Perez de Isla
    Cardiology Department Hospital Clínico San Carlos, IdISSC, Madrid, Spain Fundación Hipercolesterolemia Familiar, Madrid, Spain Electronic address
    J Am Coll Cardiol 67:1278-85. 2016

Collaborators

Detail Information

Publications16

  1. doi request reprint Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation
    Rodrigo Alonso
    Department of Internal Medicine, IIS Fundación Jiménez Díaz, Madrid, Spain Electronic address
    J Am Coll Cardiol 63:1982-9. 2014
    ..The aim of this study was to determine the relationship between lipoprotein(a) [Lp(a)] and cardiovascular disease (CVD) in a large cohort of patients with heterozygous familial hypercholesterolemia (FH)...
  2. doi request reprint Early diagnosis and treatment of familial hypercholesterolemia: improving patient outcomes
    Rodrigo Alonso
    Lipid Clinic, Internal Medicine Department, IIS Fundación Jiménez Díaz, Madrid, Spain
    Expert Rev Cardiovasc Ther 11:327-42. 2013
    ....
  3. doi request reprint Cardiovascular disease in familial hypercholesterolaemia: influence of low-density lipoprotein receptor mutation type and classic risk factors
    R Alonso
    Lipid Clinic, Fundacion Jimenez Diaz, Madrid, Spain
    Atherosclerosis 200:315-21. 2008
    ....
  4. pmc R353Q polymorphism in the factor VII gene and cardiovascular risk in Heterozygous Familial Hypercholesterolemia: a case-control study
    Juan Criado-García
    Lipids and Atherosclerosis Unit, Department of Medicine, IMIBIC Hospital Universitario Reina Sofía Universidad de Córdoba, Spain
    Lipids Health Dis 10:50. 2011
    ..To date, no study has evaluated the association between factor VII and coronary artery disease in patients with FH...
  5. pmc Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART)
    Nelva Mata
    Department of Epidemiology, Madrid Health Authority and Fundación Hipercolesterolemia Familiar, Madrid, Spain
    Lipids Health Dis 10:94. 2011
    ..Despite the use of statins, most patients do not achieve an optimal LDL-cholesterol goal. The aims of this study are to describe baseline characteristics and to evaluate Lipid Lowering Therapy (LLT) in FH patients recruited in SAFEHEART...
  6. doi request reprint Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study)
    Leopoldo Perez de Isla
    From the Cardiology Department, Hospital Clinico San Carlos, IdISSC, Madrid, Spain L P d I Fundación Hipercolesterolemia Familiar, Madrid, Spain L P d I, R A, N M, A s, P M Clínica las Condes, Santiago de Chile, Chile R A Department of Epidemiology, Madrid Health Authority, Spain N M Cardiology Department, Hospital del Tajo, Aranjuez, Madrid, Spain A S Department of Internal Medicine, Hospital Virgen del Rocio, Sevilla, Spain O M Department of Internal Medicine, Hospital SAS de Jerez de la Frontera, Cadiz, Spain P R M Department of Internal Medicine, Hospital Abente y Lago, A Coruna, Spain J L D D Department of Internal Medicine, Hospital Universitario, Reina Sofia, Cordoba, Spain F F Department of Internal Medicine, Fundacion Jimenez Diaz, Madrid, Spain R d A Lipid Clinic, Endocrinology Service Hospital Clínic, Barcelona
    Arterioscler Thromb Vasc Biol 36:2004-10. 2016
    ..Our aim was to analyze ASCVD prevalence and characteristics in different arterial territories in a large FH population, to compare them with an unaffected control population and to determine which factors are associated to ASCVD...
  7. ncbi request reprint Benefits and risks assessment of simvastatin in familial hypercholesterolaemia
    Rodrigo Alonso
    Fundacion Jimenez Diaz, Lipid Clinic, Internal Medicine Department, Madrid 28040, Spain
    Expert Opin Drug Saf 4:171-81. 2005
    ..The efficacy and tolerability of simvastatin at doses up to 80 mg/day are well-established, as well as its cost-effectiveness in the management of FH patients...
  8. doi request reprint Attainment of LDL Cholesterol Treatment Goals in Children and Adolescents With Familial Hypercholesterolemia. The SAFEHEART Follow-up Registry
    Adriana Saltijeral
    Sección de Cardiología, Hospital Universitario del Tajo, Universidad Alfonso X El Sabio, Aranjuez, Madrid, Spain Electronic address
    Rev Esp Cardiol (Engl Ed) . 2016
    ..Our aim was to evaluate the achievement of low-density lipoprotein cholesterol (LDL-C) treatment goals in FH patients younger than 18 years enrolled in a large national registry...
  9. doi request reprint Detection of subclinical atherosclerosis in familial hypercholesterolemia using non-invasive imaging modalities
    Paloma Caballero
    Department of Radiology, Hospital de la Princesa, Madrid, Spain
    Atherosclerosis 222:468-72. 2012
    ..To investigate the extent of subclinical atherosclerosis in asymptomatic familial hypercholesterolemia (FH) patients using non-invasive images techniques...
  10. doi request reprint Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up
    Leopoldo Perez de Isla
    Cardiology Department Hospital Clínico San Carlos, IdISSC, Madrid, Spain Fundación Hipercolesterolemia Familiar, Madrid, Spain Electronic address
    J Am Coll Cardiol 67:1278-85. 2016
    ..There are sparse data on attainment of treatment targets; large registries that reflect real-life clinical practice can uniquely provide this information...
  11. doi request reprint Genetic diagnosis of familial hypercholesterolemia using a DNA-array based platform
    Rodrigo Alonso
    Lipid Clinic, Fundacion Jimenez Diaz, Madrid, Spain
    Clin Biochem 42:899-903. 2009
    ..This platform includes the use of a DNA micro array, the detection of large gene rearrangements and the complete resequencing of the low-density lipoprotein receptor gene...
  12. doi request reprint Cost-effectiveness of managing familial hypercholesterolemia using atorvastatin-based preventive therapy
    Rodrigo Alonso
    Unidad de Lipidos, Fundacion Jimenez Diaz, Madrid, Spain
    Rev Esp Cardiol (Engl Ed) 61:382-93. 2008
    ....
  13. ncbi request reprint MEDPED and the Spanish Familial Hypercholesterolemia Foundation
    Pedro Mata
    Unidad de Lipidos, Fundacion Jimenez Diaz, Madrid, Spain
    Atheroscler Suppl 2:9-11. 2002
    ..Analysis of LDL-receptor gene have been performed in 350 cases and 86 different mutations have been found...
  14. ncbi request reprint [Cost-effectiveness of managing familial hypercholesterolemia using atorvastatin-based preventive therapy]
    Rodrigo Alonso
    Unidad de Lipidos, Fundacion Jimenez Diaz, Madrid, Espana
    Rev Esp Cardiol 61:382-93. 2008
    ....
  15. ncbi request reprint Benefits and risks of simvastatin in patients with familial hypercholesterolaemia
    Pedro Mata
    Lipid Clinic, Internal Medicine Department, Fundacion Jimenez Diaz, Madrid, Spain
    Drug Saf 26:769-86. 2003
    ..Early intervention with simvastatin treatment can be successfully implemented with favourable economic benefits...
  16. doi request reprint Omega-3 fatty acids and blood pressure
    Jorge Cabo
    Internal Medicine Department, Hospital Universitario Santa Cristina, Madrid, Spain
    Br J Nutr 107:S195-200. 2012
    ..3 polyunsaturated fatty acids consumption might have a place in the control of patients with mild hypertension before starting drug treatment and of those who prefer changes of lifestyles like diet...